Fedor Galkin

Mr. Fedor Galkin

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2023 in Ageing Research Reviews
Verified
Journal Article
Open access
FGFedor Galkin
Fedor Galkin
OKOlga Kovalchuk
Olga Kovalchuk
DKDiana Koldasbayeva
Diana Koldasbayeva
AZAlex Zhavoronkov
Alex Zhavoronkov
EBEvelyne Bischof
Evelyne Bischof
Epigenetic aging clocks have gained significant attention as a tool for predicting age-related health conditions in clinical and research settings. They have enabled geroscientists to study the underlying mechanisms of aging and assess the effectiveness of anti-aging therapies, including diet, exercise and environmental exposures. This review explores the effects of modifiable lifestyle factors' on the global DNA methylation landscape, as seen by aging clocks. We also discuss the underlying mechanisms through which these factors contribute to biological aging and provide comments on what these findings mean for people willing to build an evidence-based pro-longevity lifestyle.

27 September 2022 in Aging
Verified
Journal Article
Open access
PDF file
FGFedor Galkin
Fedor Galkin
KKKirill Kochetov
Kirill Kochetov
DKDiana Koldasbayeva
Diana Koldasbayeva
MFManuel Faria
Manuel Faria
HFHelene H. Fung
Helene H. Fung
AZAlex Zhavoronkov
Alex Zhavoronkov
We have developed a deep learning aging clock using blood test data from the China Health and Retirement Longitudinal Study, which has a mean absolute error of 5.68 years. We used the aging clock to demonstrate the connection between the physical and psychological aspects of aging. The clock detects accelerated aging in people with heart, liver, and lung conditions. We demonstrate that psychological factors, such as feeling unhappy or being lonely, add up to 1.65 years to one’s biological age, and the aggregate effect exceeds the effects of biological sex, living area, marital status, and smoking status. We conclude that the psychological component should not be ignored in aging studies due to its significant impact on biological age.

1 January 2019 in Ageing Research Reviews
Verified
Journal Article
Closed access
FGFedor Galkin
Fedor Galkin
BZBohan Zhang
Bohan Zhang
SDSergey Dmitriev
Sergey Dmitriev
VGVadim N Gladyshev
Vadim N Gladyshev

28 December 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
FGFedor Galkin
Fedor Galkin
AAAleksandr Aliper
Aleksandr Aliper
ELEugene Lane
Eugene Lane
IKIgor Kuznetsov
Igor Kuznetsov
VGVadim N Gladyshev
Vadim N Gladyshev
EPEvgeny Putin
Evgeny Putin
Graphical The human gut microbiome is a complex ecosystem that both affects and is affected by its host status. Previous analyses of gut microflora revealed associations between specific microbes and host health and disease status, genotype and diet. Here, we developed a method of predicting biological age of the host based on the microbiological profiles of gut microbiota using a curated dataset of 1,165 healthy individuals (3,663 microbiome samples). Our predictive model, a human microbiome clock, has an architecture of a deep neural network and achieves the accuracy of 3.94 years mean absolute error in cross-validation. The performance of the deep microbiome clock was also evaluated on several additional populations. We further introduce a platform for biological interpretation of individual microbial features used in age models, which relies on permutation feature importance and accumulated local effects. This approach has allowed us to define two lists of 95 intestinal biomarkers of human aging. We further show that this list can be reduced to 39 taxa that convey the most information on their host’s aging. Overall, we show that (a) microbiological profiles can be used to predict human age; and (b) microbial features selected by models are age-related.

25 July 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
FGFedor Galkin
Fedor Galkin
VNVladimir Naumov
Vladimir Naumov
SPStefan Pushkov
Stefan Pushkov
DSDenis Sidorenko
Denis Sidorenko
AUAnatoly Urban
Anatoly Urban
AZAlex Zhavoronkov
Alex Zhavoronkov
We present a multimodal multi-species multi-omics multi-tissue transformer for aging research and drug discovery capable of performing multiple tasks such as age prediction across species, target discovery, tissue, sex, and disease sample classification, drug sensitivity prediction, replication of omics response and prediction of biological and phenotypic response to compound treatment. This model combines textual, tabular, and knowledge graph-derived representations of biological experiments to provide insights into molecular-level biological processes. We demonstrate that P3GPT has developed an intuition for the interactions between compounds, pathologies, and gene regulation in the context of multiple species and tissues. In these areas, it outperforms existing LLMs and we highlight its utility in diverse case studies. P3GPT is a general model that may be used as a target identification tool, aging clock, digital laboratory, and scientific assistant. The model is intended as a community resource available open source as well as via a Discord server.

14 July 2021 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
VNVladimir Naumov
Vladimir Naumov
ELEugene Lane
Eugene Lane
SPStefan Pushkov
Stefan Pushkov
EKEkaterina Kozlova
Ekaterina Kozlova
KRKonstantin Romantsov
Konstantin Romantsov
EPEvgeny Putin
Evgeny Putin
Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we introduce COVIDomic, a multi-omics online platform designed to facilitate the analysis and interpretation of the large amount of health data collected from patients with COVID-19. The COVIDomic platform provides a comprehensive set of bioinformatic tools for the multi-modal metatranscriptomic data analysis of COVID-19 patients to determine the origin of the coronavirus strain and the expected severity of the disease. An integrative analytical workflow, which includes microbial pathogens community analysis, COVID-19 genetic epidemiology and patient stratification, allows to analyze the presence of the most common microbial organisms, their antibiotic resistance, the severity of the infection and the set of the most probable geographical locations from which the studied strain could have originated. The online platform integrates a user friendly interface which allows easy visualization of the results. We envision this tool will not only have immediate implications for management of the ongoing COVID-19 pandemic, but will also improve our readiness to respond to other infectious outbreaks.